Last reviewed · How we verify
NCT06105242
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
trial in CTEPH in 10 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Intermountain Health Care, Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 30 May 2022 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Conditions studied
- CTEPH — all drugs for CTEPH →
Sponsor
Intermountain Health Care, Inc. — full company profile →
Who can join
18 and older, any sex, with CTEPH. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. To identify biological sex differences in baseline RV function in CTEPH 2. To identify biological sex differences in recovery of RV function after PTE surgery in CTEPH 3. To determine if sex hormone levels relate to RV function at CTEPH diagnosis and during recovery after PTE.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06105242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CTEPH
Currently open trials in the same condition.
- NCT07522203 — Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension U · recruiting
- NCT07299227 — Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics · recruiting
- NCT05140525 — Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH · Phase 3 · recruiting
Other Intermountain Health Care, Inc. trials
Trials by the same sponsor.
- NCT07334795 — Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics · active not recruiting
- NCT07348289 — PIVO Use for Blood Cultures in the Emergency Department · recruiting
- NCT06865781 — Vital Signs Reduction Study · NA · active not recruiting
- NCT05936021 — Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease U · NA · unknown
- NCT05141396 — Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06105242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intermountain Health Care, Inc.
- Last refreshed: 27 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06105242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing